Erez Chimovits, a director at $BRVE, bought 1,666,667 shares of the company on 08-07-2026 for an estimated $30,000,006. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 16.3%. Following this trade, they now own 11,901,826 shares of this class of $BRVE stock.
$BRVE Insider Trading Activity
$BRVE insiders have traded $BRVE stock on the open market 12 times in the past 6 months. Of those trades, 12 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BRVE stock by insiders over the last 6 months:
- GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. FORBION has made 2 purchases buying 3,600,000 shares for an estimated $64,800,000 and 0 sales.
- ADVISORS LLC ORBIMED has made 2 purchases buying 1,940,000 shares for an estimated $34,920,000 and 0 sales.
- EREZ CHIMOVITS has made 2 purchases buying 1,940,000 shares for an estimated $34,920,000 and 0 sales.
- CHRISTOPHER VIEHBACHER purchased 83,333 shares for an estimated $1,499,994
- TRAVIS MURDOCH (CEO and President) purchased 83,333 shares for an estimated $1,499,994
- DAVID CHARLES LUBNER purchased 55,555 shares for an estimated $999,990
- JAMES PAUL RICKEY (Chief Financial Officer) purchased 27,777 shares for an estimated $499,986
- DAVID I MALEK purchased 4,166 shares for an estimated $74,988
- MICHELE A. ANDERSON (Chief Development Officer) purchased 1,111 shares for an estimated $19,998
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
